Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Veterinary and Human Toxicology|November 27, 1998
Bee pseudocholinesterase as an indicator of exposure to anticholinesterase insecticidesM Stefanidou, F Pappas, G Methenitou, et al.Clinical Endocrinology|November 1, 1992
Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolismH Matzkin, J Chen, Y Weisman, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1992
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasiaJ D McConnell, J D Wilson, F W George, et al.European Urology|January 1, 1992
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasiaH O Beisland, B Binkowitz, E Brekkan, et al.European Urology|November 30, 2000
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trialsM J Marberger, J T Andersen, J C Nickel, et al.Urology|October 6, 2000
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study GroupS Kaplan, D Garvin, P Gilhooly, et al.Urology|December 12, 2002
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasiaD Vaughan, J Imperato-McGinley, J McConnell, et al.Journal of the American Academy of Dermatology|October 26, 2000
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopeciaV H Price, J L Roberts, M Hordinsky, et al.Pageof 2